Price
114.55
+1.95%Market Cap
₹550.09 Cr
Traded: ₹0.01 Cr (0.00%) 0.0x
Free Float: ₹381.71 Cr (0.00% of FF traded)
Volume · 60D trend
1.16 K 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| ROE | -4.0% | -6.0% | -5.0% | -- | -- | Stable |
| Return | -- | -- | +38.0% | -- | -- | -- |
| Profit | -- | -- | -- | -- | -186.0% | -- |
| Sales | -- | -- | -- | -- | -100.0% | -- |
Quarterly Results
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023PDF ↗ | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,991 | 911 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 2,594 | 772 | 0 | 0 | 29 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit | 397 | 139 | -0 | -0 | -29 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| OPM % | 13.0% | 15.0% | -- | -- | -- | -- | -53.9% | -283.3% | -111.1% | -271.4% | -100.0% | -128.6% | -157.1% | -362.5% |
| Other Income | 19 | 130 | 0 | 0 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 139 | 41 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 220 | 62 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 56 | 166 | -0 | -0 | -25 | -0 | 1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Tax % | 5.0% | 11.0% | 0.0% | 0.0% | 0.0% | 40.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | 53 | 147 | -0 | -0 | -25 | -0 | 1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Exceptional Items | -- | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 8.0 | 26.4 | -0.2 | -0.4 | -33.7 | -0.7 | 1.8 | -0.5 | -0.2 | -0.4 | -0.1 | -0.2 | -0.0 | -0.9 |
| Sales Growth (YoY) | -- | -- | -100.0% | -100.0% | -100.0% | -100.0% | 85.7% | -14.3% | 28.6% | -12.5% | -- | -- | -- | -- |
| Sales Growth (QoQ) | -- | -- | -- | -- | -- | -100.0% | 116.7% | -33.3% | 28.6% | 0.0% | 0.0% | 0.0% | -12.5% | -- |
| OP Growth (YoY) | 1469.0% | 73257.9% | -200.0% | -94.1% | -28900.0% | 0.0% | 0.0% | -88.9% | 9.1% | 34.5% | -- | -- | -- | -- |
| OP Growth (QoQ) | 185.6% | 66290.5% | 36.4% | 98.9% | -15163.2% | -171.4% | 58.8% | -70.0% | 47.4% | -171.4% | 22.2% | 18.2% | 62.1% | -- |
| Profit Growth (YoY) | 252.0% | -- | -433.0% | -121.0% | -- | -62.0% | 25.0% | -180.0% | -400.0% | 54.0% | 0.0% | -25.0% | 88.0% | -- |
| EPS Growth (YoY) | -- | 81.4% | -111.9% | 12.8% | -94.1% | -62.8% | 1461.5% | -176.5% | -466.7% | 53.8% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | 38.1% | 48.8% | -24.2% | 52.9% | -139.6% | 476.6% | -176.5% | 60.5% | -230.8% | 23.5% | -466.7% | 96.8% | -- |
| OP Margin | -- | -- | -- | -- | -- | -- | -53.9% | -283.3% | -111.1% | -271.4% | -100.0% | -128.6% | -157.1% | -362.5% |
| Net Margin | -- | -- | -- | -- | -- | -- | 407.7% | -233.3% | -55.6% | -185.7% | -57.1% | -71.4% | -14.3% | -350.0% |
| Material Cost % | 16.8% | 13.9% | -- | -- | -- | -- | 76.9% | 83.3% | 77.8% | 0.0% | 85.7% | 85.7% | 85.7% | 75.0% |
| Employee Cost % | 18.3% | 19.1% | -- | -- | -- | -- | 30.8% | 66.7% | 44.4% | 71.4% | 57.1% | 42.9% | 57.1% | 62.5% |
| P/S | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | -- | 9.31 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/08/2026 ,inter alia, to consider and approve Material Related Party Transaction ....
Intimation for the shifting of Registered office of the Company from State of Assam to State of Maharashtra in Form INC-26
Attached is the Scrutinizer Report of Postal Ballot.
Pursuant to the meeting of Board of Directors held on 12th August 2026, the unaudited Financial Results for the 1st Quarter ended 30th June 2026 published in 2 newspapers such as Financial ....
Outcome of the Board Meeting as per attached PDF.
Unaudited Financial Results for the first quarter ended 30 June 2026.
Statement of Deviation for the quarter ended 30 June 2026 is not applicable.
Annual Secretarial Compliance Report for the fy 25-26.
Proposed incorporation of Wholly Owned Private Limited Company.
Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
News Paper Publication pertaining to Corrigendum of Postal Ballot dated 17 July 2026.
Please read postal ballot notice with updated changes
Regarding Postal Ballot Notice Sent on 13 July 2026. The newspaper publication was done on 14 July 2026.
The postal ballot will open on 15-July-2026 at 9:00 A.M. Last date being 13-August-2026 at 5:00 P.M. Details of agenda are enclosed.
As per attached Outcome.
The board has approved resolution regarding Preferential Allotment and Rights Issue.
Board Meeting approved the acquisition of the SIGPL.
Board has approved preferential allotment in meeting dated 11 July 2026
The Board has approved shifting of RO from Assam to Maharashtra, Subject to regulatory Approvals.
This is in continuation with previous disclosure dated May 12 2026 in connection with name change of company which now noted by BSE also.
Certificate under Regulation 74 (5) of SEBI (DP) regulation
Bijoy Hans Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 ,inter alia, to consider and approve 1. To consider & approve Acquisition ....
Based on the recommendation of Nomination & Remuneration Committee, approved the appointment of Mr. Bidari Kotresh Anilkumar (DIN: 06624790) as an Additional Director designated as Executive ....
Appointment of Mr. Bidari Kotresh Anilkumar (DIN:06624790) as Additional Director to be designated as Executive Director of the company.
Bijoy Hans Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/07/2026 ,inter alia, to consider and approve Mr. Bidari Kotresh Anilkumar as ....
Approval Letter for Re-classification of Shareholders under Regulation 31A of SEBI LODR Regulations, 2015.
The closure of trading window for the First Quarter Ended 30th June, 2026.
Due to minor inadvertent error the company is filing with Corrigendum for Audited Financials Results for 31st March 2025.
Due to minor inadvertent error the company is filing Corrigendum for 31st March 2026
Newspaper Publications for Audited Standalone & Consolidated Financial Statement for the year ended 31 March 2026.
1. Approved Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2026. The said Audited Financial Results prepared in ....
Audited Financial Results for the year ended 31 March 2026.
Resignation of CA Ashlesh Parnawar as Internal Auditor and appointment of M/s. G. K. Vora & Co. as an Internal Auditor of the Company for the F.Y. 2026-27.
Statement of Deviation(s) and/or variation(s) pursuant to Regulation 32 of the SEBI LODR for the quarter ended 31 March 2026.
The Company will comply Reg. 24(A) within six months from the date of exceeding exemption threshold dated 4 March, 2026.
Bijoy Hans Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve To consider & approve the Audited ....
The name of company is changed from BIJOY HANS LIMITED to ARVAYA HEALTHCARE LIMITED, with effect from 11th May 2026.
Adoption & Constitution of TCWG Committee along with its Policy.
Company has received Trading Approval obtained from BSE Limited for 4,05,21,836 Equity Shares of Rs. 10/- each issued at a Premium of Rs. 2.50/- to Promoters and Non-Promoters on a Preferential basis.
Voting Results with Scrutinizers Report
Certificate under Regulation 74(5) of SEBI (Depository Participant) Regulations, 2018 for the quarter ended 31 March 2026.
Newspaper Advertisement of Form INC-26 regarding Shifting of Registered office from State of Assam to State of Maharashtra.
Annual Disclosure given by promoter of the Company for the as on 31 March 2026.
The Company has received Listing Approval from BSE Limited vide their letter LOD/PREF/DA/FIP/17/2026-27 dated 2 April, 2026.
Intimation for Closure of Trading Window for the fourth quarter and year ended 31 March, 2026.
Closure of Trading Window for the quarter and year ended 31 March 2026
Newspaper Publishment regarding Postal Ballot notice dated 19 March 2026.
Postal Ballot Notice dated 19 March 2026
The company has received the order from Calcutta Stock exchange regarding delisting of shares. Effective From 18th of March 2026. The share of the company are only Listed on Bombay Stock ....
Pursuant to Regulation 30 and other applicable provisions read with Schedule III of the SEBI LODR Regulations, 2015 ('SEBI Listing Regulations'), as amended from time to time, we wish to ....